GRF(1-29) raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-03-28 and is reviewed periodically as new material appears.
CJC-1295 belongs to a family of synthetic peptides modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound is built from the first twenty-nine amino acids of the natural human sequence, a fragment that retains full receptor binding capacity. Native growth hormone-releasing hormone is degraded quickly in circulation, so the fragment alone has limited practical value. Early work therefore focused on chemical modifications that preserve receptor binding while slowing enzymatic breakdown. The result is a molecule described in the literature as a long-acting analog of the natural hormone.
Two forms circulate under the CJC-1295 name, and they differ by a single appended group. The version without a drug affinity complex carries four substitutions along the peptide chain, including a D-alanine near the amino terminus and replacements at three other positions. These changes block the enzyme dipeptidyl peptidase IV and remove a methionine residue that is prone to oxidation. The modified fragment is frequently labeled MOD GRF 1-29. Naming conventions are inconsistent across informal sources, which is a common source of confusion.
The second form adds a maleimide-bearing linker to the lysine at the carboxyl end. This group reacts with cysteine-34 on circulating serum albumin, forming a covalent bond that keeps the peptide in the bloodstream for far longer. ConjuChem developed the molecule as a way to extend the action of a peptide without frequent administration. The albumin attachment is the defining structural feature of the drug affinity complex version. Whether continuous exposure produces effects distinct from shorter pulses remains an unresolved research question.
CJC-1295 is a synthetic peptide analog of growth hormone-releasing hormone, constructed on the 29-amino-acid fragment designated GRF(1-29). The name began as an internal development code during the 1990s and later spread through research supply catalogs and discussion forums. The molecule does not occur in nature; its sequence is engineered rather than isolated from tissue. Two related compounds are sold under this single label, and they differ by one appended chemical group that strongly influences how long the peptide remains in circulation.
The dividing feature between the two forms is a maleimide-based drug affinity complex, abbreviated DAC. In the DAC-bearing version, a linker attaches the peptide to serum albumin after administration, and that association slows removal from plasma. The version lacking DAC appears in catalogs as MOD GRF(1-29) or tetrasubstituted GRF(1-29). Because informal writing treats both as one item, comparisons drawn from such sources routinely blend measurements taken from two molecules with substantially different behavior.
Four amino acid substitutions separate the modified backbone from the parent GRF(1-29) sequence. These changes reduce recognition by dipeptidyl peptidase IV and related proteases, extending the interval before degradation. Development work in this area sought longer-acting GHRH analogs for endocrine investigation. Published descriptions treat the substitution set as a defining property of the core sequence, while the albumin-binding linker is described separately as an optional addition to that same backbone.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Analog of growth hormone-releasing hormone |
| Chain length | 29 amino acids | Based on the GRF(1-29) fragment |
| Appearance | White to off-white lyophilized powder | Common research supply form |
| Solubility | Soluble in water and aqueous buffers | Powder requires reconstitution before use |
| Typical storage | −20 °C or below | Kept away from light and moisture |
Binding of the peptide to the growth hormone-releasing hormone receptor on pituitary somatotrophs triggers a G protein coupled cascade that raises cyclic AMP and opens calcium channels. The result is greater secretion of growth hormone into the bloodstream. Because the peptide acts at the same receptor as the natural hypothalamic hormone, its effect is amplified pulse size rather than an entirely separate release pathway. Receptor binding alone does not determine the response, since somatostatin tone and other inputs modulate the final output.
The albumin-binding version stays in circulation for days, because covalent attachment to serum albumin shields the peptide from rapid filtration and degradation. Reported half-lives for this form fall in the range of several days. The version without the linker is cleared in minutes, with estimates often near thirty minutes in animal work. These figures come from small studies and vary with assay method, species, and route, so they are best read as approximate rather than fixed constants.
Lyophilized peptide powder is comparatively stable when kept dry, cold, and protected from light. Once dissolved, the molecule is vulnerable to deamidation, oxidation, and aggregation, with the rate depending on pH, buffer composition, and temperature. Alkaline conditions and repeated freeze-thaw cycles accelerate loss of the intact peptide. The methionine present in the native sequence is a known oxidation site, which is one reason it was replaced in the modified fragment. Suppliers typically recommend cold storage of solutions and use within a short window.
Analytical confirmation usually relies on reversed-phase high-performance liquid chromatography for purity and on liquid chromatography coupled to mass spectrometry for identity. Mass data reveal the expected molecular mass and can flag truncated or oxidized species. Amino acid analysis and peptide mapping provide sequence-level verification. Immunoassays are used in some biological matrices, but antibodies raised against one releasing-hormone analog may cross-react with another. Reported purity figures depend heavily on the method used, so comparisons between suppliers require matching the analytical approach.
Electronic cigarette aerosol contains fine and ultrafine particles of particulate matter, including particulate matter 2.5 μm or smaller in diameter (PM2.5). Studies have found that electronic cigarette aerosol can raise PM2.5 concentrations to several hundred micrograms per cubic meter (μg/m³), with measurements of 600–800 μg/m³ in vape shops and conventions and peak values exceeding 1,000 μg/m³; these levels are far above typical indoor backgrounds (8–52 μg/m³) and greatly exceed the World Health Organization’s 24‑hour PM2.5 guideline of 25 μg/m³ for outdoor air. PM2.5 is capable of penetrating deep into the lungs and entering the bloodstream, where it is associated with severe systemic inflammation, cardiovascular disease, and premature death.
de novo mutation A spontaneous mutation in the genome of an individual organism that is new to that organism's lineage, having first appeared in a germ cell of one of the organism's parents or in the fertilized egg that develops into the organism; i.e. a mutation that was not present in either parent's genome.
The objectives of the Party of European Socialists, the European Parliament's social democratic bloc, are now "to pursue international aims in respect of the principles on which the European Union is based, namely principles of freedom, equality, solidarity, democracy, respect of Human Rights and Fundamental Freedoms, and respect for the Rule of Law." As a result, today the rallying cry of the French Revolution—Liberté, égalité, fraternité—is promoted as essential socialist values. To the left of the European Socialists at the European level is the Party of the European Left, a political party at the European level and an association of democratic socialist and communist parties in the European Union and other European countries. It was formed for the purposes of running in the 2004 European Parliament election. The European Left was founded on 8–9 May 2004 in Rome. Elected MEPs from member parties of the European Left sit in the European United Left–Nordic Green Left group in the European Parliament. The democratic socialist Left Party in Germany grew in popularity, as did popular dissatisfaction with the increasingly neoliberal policies of the Social Democratic Party of Germany after Gerhard Schröder's tenure as Chancellor, becoming the fourth biggest party in parliament in the general election on 27 September 2009. In 2008, the Progressive Party of Working People candidate Dimitris Christofias won a crucial presidential runoff in Cyprus, defeating his conservative rival with a majority of 53%.
Sources: en.wikipedia.org
== Career == Goodacre joined the University of Oxford as a research fellow in 1999. She was a research fellow at the University of East Anglia from 2002. She was described by the BBC as Spider Woman. As of 2018, Goodacre is based at the University of Nottingham, where she founded the SpiderLab in 2007 and leads the ArachNotts research group. As a geneticist, Goodacre studies the evolution, population and conservation of spiders. She monitored the mating behaviour and sex ratio of the linyphiid spider Pityohyphantes phrygianus with Bengt Gunnarsson at the University of Gothenburg. She also studied the silk of Mygalomorphae spiders and the genetic diversity of spider silk genes and found evidence for antimicrobial activity in the silk of common house spiders. She found that Erigone atra, a pest controlling spider, uses long-distance airborne dispersal. Goodacre contributed to the 2011 book Spider Physiology and Behaviour: Physiology. In 2015 Goodacre reported that spiders could survive "sailing" across oceans. ArachNotts study the diving bell spider and its silk, which it uses to build a diving bell in which it stores air underwater, and have so far identified some of the silk genes used by this spider. They also work on the relationship between spiders and the microbes that they carry with them, including the mating behaviour and sex-ratio of offspring, the ecology and biological control potential of spiders in agriculture and the use of genetic tools in the conservation of the endangered raft spider.
=== Economics === Copra production begins on coconut plantations. Coconut trees are generally spaced 9 m (30 ft) apart, allowing a density of 100–160 coconut trees per hectare. A standard tree bears around 50–80 nuts a year, and average earnings in Vanuatu (1999) were US$0.20 per kg (one kg equals 8 nuts)—so a farmer could earn approximately US$120 to US$320 yearly for each planted hectare. Copra has since more than doubled in price, and was quoted at US$540 per ton in the Philippines on a CIF Rotterdam basis (US$0.54 per kg) by the Financial Times on 9 November 2012. In 2017 the value of global exports of copra was $145-146 Million. The largest exporter was Papua New Guinea with 35% of the global total, followed by Indonesia (20%), Solomon Islands (13%) and Vanuatu (12%). The largest importer of copra is the Philippines, which imports $93.4 Million or 64% of the global total. A very large number of small farmers and tree owners produce copra, which is a vital part of their income.
==== Detailed ADH pathway ==== The reaction from ethanol to carbon dioxide and water proceeds in at least 11 steps in humans. C2H6O (ethanol) is converted to C2H4O (acetaldehyde), then to C2H4O2 (acetic acid), then to acetyl-CoA. Once acetyl-CoA is formed, it is free to enter directly into the citric acid cycle (TCA) and is converted to 2 CO2 molecules in 8 reactions. The equations:
Sources: en.wikipedia.org
== Pharmacokinetics == When administered orally once a day, mavatrep reached steady-state in healthy volunteers in approximately 14 days. It has a relatively long half-life between 68 and 101 hours in Japanese subjects and between 82 and 130 hours in Caucasian subjects. Mavatrep is largely eliminated non-renally. Mavatrep appears to be metabolized into two primary metabolites which are also eliminated nonrenally.
Hyperphagia or polyphagia is common within Alström populations and has been shown to contribute to weight gain. Moderate to severe hypertriglyceridemia occurs in most individuals. Almost all individuals with AS experience insulin resistance and/or hyperinsulinemia to some degree. Therefore, type 2 diabetes mellitus often results as early as 5 years of age with a median onset of 16 years. Non-alcoholic fatty liver disease is common in AS. This often progresses to non-alcoholic steatohepatitis. Upper and lower respiratory tract infections in childhood, which decrease during adulthood. Bronchitis, pneumonia, and sinusitis have also been reported. Increased susceptibility to hypoxemia during or after surgery. Chronic obstructive pulmonary disease, interstitial lung disease, or acute respiratory distress syndrome is also seen in some older patients. Chronic kidney disease is common in some cases that can lead to end-stage renal disease/kidney failure as early as mid-to late teens. Less than half of individuals experience dysuria. Epigastric pain, nausea, and gastroesophageal reflux disease are common. Delays in gross and fine motor skills, learning disabilities, and mixed receptive-expressive language delays are common. Cognitive impairment, however, is very rare. Delays in early, developmental milestones in 50% of cases, learning disabilities in about 30% of cases. Seizures and hyporeflexia have been reported but are less common (20% of individuals).
=== Pirkle-type CSP === Pirkle and co-workers pioneered the development of a variety of CSPs based on charge-transfer complexation and simultaneous hydrogen bonding. These phases are also referred to as Brush-type CSPs. The Pirkle phases are based on aromatic π-acid (3,5-dinitrobenzoyI ring) and π- basic (naphthalene) derivative. In addition to π-π interaction sites, they have hydrogen-bonding and dipole-dipole interaction sites provided by an amide, urea or ester functionality. Strong three-point interaction, according to Dalgleish's model, enables enantioseparation. These phases are classified into π-electron-acceptor, π-electron-donor or π-electron acceptor-donor phase. A number of Pirkle-type CSPs are commercially available. They are used most often in the normal phase mode. The ionic form of the DNPBG (3,5-dinitrobenzoyl-phenylglycine) CSP has been successfully employed to achieve separation of racemic propranolol in biological fluid. Many compounds of pharmaceutical interest including enantiomers of naproxen and metoprolol has been separated using Pirkle CSP.
It was the only instrument in use around 1930, but it was not widely accepted in medical circles. Treatment of acne with ultraviolet radiation is still controversial. Although UV radiation can have an antibacterial effect, it can also induce proliferative hyperkeratosis. This can lead to the formation of comedones ("blackheads"). Phototoxic effects may also occur. In addition, it is carcinogenic and promotes skin aging. UV therapy is increasingly being abandoned in favor of photodynamic therapy.
Sources: en.wikipedia.org
No. It is a laboratory-synthesized analog built on a fragment of the natural hormone. The natural peptide is shorter-lived and lacks the stabilizing substitutions found in the synthetic version.
DAC stands for drug affinity complex, a chemical group that binds the peptide to serum albumin. The binding slows clearance and lengthens the time the molecule stays in plasma compared with the unmodified analog.
Because two distinct molecules are discussed under one informal label. The albumin-binding version clears over several days, while the form without that group clears within roughly half an hour. Mixing results from both creates inconsistent figures.
Reported values cluster in the range of several days, reflecting slow release from the albumin complex. Estimates differ across species and assay platforms. The figure describes circulation time in study settings rather than a fixed property.